CTI BioPharma Corp(NASDAQ:CTIC) 
CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It develops pacritinib, an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CS...
Website: http://www.ctibiopharma.com
Full Time Employees: 25
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2022-12-23
P
O 5.69
H 5.76
L 5.50
C 5.63
V 1,539,044
10EMA 5.63
20EMA 5.63
60EMA 5.63
120EMA 5.63
250EMA 5.63